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This was a retrospective cohort study carried out in a single centre. Follow up was until discharge from hospital or 30 days in the case of neurologic complications. There appears to have been no loss to follow up.
Analysis of effectiveness
The analysis of effectiveness was based on treatment completers only, as patients who crossed over to the other group were excluded from the analysis. The primary health outcomes considered in the analysis were neurologic complications and death, and non-neurologic morbidity. Initial groups were shown to be comparable with respect to risk factors associated with carotid stenosis, although the PTAS group had a significantly greater number of patients with coronary artery disease and hypertension. The number of patients excluded from each group was similar, (p=0.380).
Effectiveness results
Neurologic deficits lasting more than 24 hours occurred after 8 of 104 PTAS (7.7%), and after 4 of 130 CE (3.1%). There was 1 death in the PTAS group (0.9%), and 2 in the CE group (1.5%). The total rate of stroke and death was 8.7% for the PTAS group and 3.1% in the CE group, (p= 0.085). The incidence of non-neurologic morbidity was 6.1% (6 out of 98 patients) in the PTAS group and 0.8% (1 of 120 patients) in the CE group.
Clinical conclusions
The risk of neurologic morbidity by PTAS did not appear to be reduced. The rate of total non-neurologic morbidity was also higher than the rate for CE.
Measure of benefits used in the economic analysis
No single measure of benefit was introduced in the economic analysis.
Direct costs
Quantities were not reported separately from costs. Only hospital costs were considered and hospital charges were used as a proxy for costs. Data were obtained from the hospital business office. The following hospital charges were included: radiology, operating room, cardiac catheterisation, and all other hospital charges. Professional fees were not included in the cost analysis. Discounting was not applied because of the short time frame of the study. 1994-95 prices were used.
